Stanford University
Showing 30,901-30,920 of 37,041 Results
-
Felice Su
Clinical Professor, Pediatrics - Critical Care
Current Research and Scholarly InterestsMy clinical pharmacology research is focused on investigating the impact of dynamic organ function on drug disposition and designing dosing strategies based on mathematical models that account for these changes in order to optimize safe medication administration in critically ill children.
Research through the REVIVE Initiative for Resuscitation Excellence investigates the quality of resuscitation during cardiopulmonary arrest. Areas of focus include early identification during the no-flow state prior to CPR initiation and quality of CPR simulation education. -
Haotian Su
Ph.D. Student in Electrical Engineering, admitted Autumn 2022
BioHaotian Su is a Ph.D. candidate in Electrical Engineering at Stanford University, co-advised by Prof. Eric Pop and Prof. Shan X. Wang. He received his B.S. in EE from National University of Singapore (2022). His research focuses on developing novel materials and thin films for energy-efficient memories and computing, including magnetic random-access memory (MRAM), oxide transistors, and other nanoscale devices.
-
Jeanne Su
Director of Finance and Operations, East Asian Languages and Cultures
Current Role at StanfordDirector of Finance and Operations at East Asian Languages and Cultures (EALC).
-
Minhui Su
Instructor, Pediatric Neurology
BioMinhui Su, PhD is a postdoctoral fellow at the Neurology Department. She is investigating neuronal activity-regulated glioma growth, specifically how membrane depolarization regulates glioma growth in the tumor microenvironment.
She obtained her PhD in Molecular Biology, with a focus on neuroimmunology, at the International Max Planck Research School (IMPRS) at Georg August University Göttingen, Germany. Her PhD research discovered that inflammation is an essential early step of myelin regeneration, and uncovered the roles of microglia (the resident immune cells of the central nervous system) in myelin damage response.
She enjoys science, art and hiking in her free time. -
Shih-Po Su
Postdoctoral Scholar, Ophthalmology
BioDr. Shih-Po Su is a Postdoctoral Research Fellow in the Department of Ophthalmology at Stanford University. He earned his Ph.D. in Biomedical Engineering from National Yang Ming Chiao Tung University (NYCU), Taiwan, in 2024. His doctoral research focused on the development of advanced optical imaging systems, including a three-dimensional near-infrared fluorescence and photoacoustic vascular imaging platform for preclinical applications.
Dr. Su has over a decade of experience in biomedical imaging, integrating optical system design, image analysis, and in vivo disease modeling. His research interests center on the interface of optical engineering and translational medicine, particularly in retinal ganglion cell (RGC) imaging and neuroprotective strategies for glaucoma. At Stanford, he is extending his expertise to short-wave infrared (SWIR/NIR-II) imaging and in vivo retinal functional imaging to establish sensitive biomarkers for neurodegeneration.
His recent work has advanced optical imaging and NIR-II contrast agents, including the co-development of polymer-dot probes for three-dimensional tumor and bone imaging (Chemical Science, 2022; Advanced Healthcare Materials, 2021) and an ultrabright polymer-dot platform for rotational stereo imaging (Advanced Healthcare Materials, 2024). He also designed integrated small-animal imaging systems combining bioluminescence tomography and ultrasound, as well as rotational stereo NIR-II fluorescence imaging (Optics Express, 2024; Journal of Biomedical Optics, 2023; Biosensors, 2022).
Dr. Su has received multiple international recognitions, including the Taiwan Science and Technology Hub@Stanford Postdoctoral Fellowship (2024), First Prize in the NYCU Annual Thesis Competition (2023), the Future Tech Award (MOST, 2022), and the MOST Pilot Scholarship Program (2019). His long-term goal is to develop regenerative medicine–based imaging and therapeutic platforms to address unmet clinical needs in neurodegenerative diseases and vision restoration.
